As of 2024-12-14, the Relative Valuation of Valeo Pharma Inc (VPH.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.59 CAD, the upside of Valeo Pharma Inc based on Relative Valuation is -101.9%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -101.5% - -102.3% | -101.9% |
| Date | P/E |